ASCO update: this article talks about the stuff th
Post# of 72440
(Total Views: 219)
Posted On: 06/06/2017 11:19:38 AM
ASCO update: this article talks about the stuff that's come out of the conference.
One of the BIG DEALS is the use of combination therapy. Keytruda is one that is frequently used as part of the combo therapy.
Let's remember that CTIX has said that combo therapy with Kevetrin is one thing they're looking at.
https://www.washingtonpost.com/news/to-your-h...acc7a87768
One of the BIG DEALS is the use of combination therapy. Keytruda is one that is frequently used as part of the combo therapy.
Quote:
Merck's drug, Keytruda, leads the pack with a role in 268 combo studies. Roy Baynes, senior vice president and head of global clinical development at Merck Research Laboratories, is blunt about the state of knowledge: “We have no idea what the best combinations are,” he said. “Anyone who tells you that they do is fibbing.”
Let's remember that CTIX has said that combo therapy with Kevetrin is one thing they're looking at.
https://www.washingtonpost.com/news/to-your-h...acc7a87768
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼